Summary
This white paper serves as a comprehensive guide for pharmaceutical manufacturers considering a migration to a new track and trace system. It outlines the challenges faced by manufacturers with existing systems that may no longer meet their business needs, including issues related to compliance, cost, and operational efficiency. The document details six critical migration considerations that manufacturers should evaluate before transitioning to a new solution. These considerations include understanding the total cost of ownership, ensuring the system goes beyond basic compliance, assessing workflow fit, evaluating serialization experience, navigating the complexities of validation, and avoiding chaos during migration. By addressing these factors, the guide aims to equip manufacturers with the knowledge to make informed decisions that minimize disruption and enhance traceability in their operations. The paper emphasizes the importance of selecting a provider that can adapt to evolving regulatory requirements and support the unique needs of the pharmaceutical industry.
